Cytoplan's revenue in 2021 & 2022 (trailing twelve months' revenue) ranges between $1M-$5M, calculated on a gross merchandise value basis.
Cytoplan sells products in the health and fitness category. There are other companies like Healthaid, Biocare, Revital, Science In Sport, The Protein Works, Water For Health, Wild Nutrition and Testogen that also sell products in similar or adjacent categories like vitamins and dietary supplements.
Cytoplan is either boot strapped or is a public company and so venture funding data for Cytoplan is unavailable.
Cytoplan's revenue in 2021 & 2022 (trailing twelve months' revenue) ranges between $1M-$5M, calculated on a gross merchandise value basis. Typically eCommerce companies are valued at 1-1.5x their trailing twelve months' gross merchandise value. So we expect Cytoplan valuation to be in the range of $1M-$7.5M. Actual valuations may vary.
Cytoplan's headquarters is in United Kingdom. The headquarters address is Unit 8 Hanley Workshops, Hanley Swan, Worcestershire, WR8 0DX, United Kingdom.
Cytoplan is a dtc company. They sell through own web store. Cytoplan's customers are B2C.
Based on PipeCandy's proprietary Commercepedia maturity scoring model, Cytoplan's scores 71/100. We classify them as an upper mid-market company.